SAVE Moms and Babies Act of 2025
U.S. Congress · HR685 ·
Progression
Timing in context
Primary sponsor's contributions received (same period)
Adjacency in time is shown for context; it is not evidence of cause. Funded ≠ false — see the methodology.
What the bill says
Introduced 2025-01-23. Latest action: Referred to the House Committee on Energy and Commerce.
Summary (plain-language)
Support And Value Expectant Moms and Babies Act of 2025 or the SAVE Moms and Babies Act of 2025 This bill prohibits the Food and Drug Administration (FDA) from approving any new drug (either as a brand-name drug or a generic) intended to terminate a pregnancy and imposes additional restrictions on such drugs that are already approved. Under the bill, an already-approved drug intended to terminate a pregnancy may be dispensed to a patient only with a prescription. Furthermore, the FDA may not approve any labeling change that would authorize (1) using the drug after 70 days of gestation, or (2) dispensing the drug by any means other than in-person administration by the prescribing health care practitioner. The FDA must also impose additional restrictions on such already-approved drugs, including by (1) requiring the prescribing health care practitioner to receive a special certification, (2) prohibiting the practitioner from also acting as the dispensing pharmacist, and (3) requiring the practitioner to have the ability to provide surgical intervention to the patient. The bill also rescinds any investigational use exemption already granted to such a drug if the bill would have prohibited the FDA from granting the exemption. (Currently, the FDA may grant an exemption to certain market approval requirements if a drug is intended solely for use in safety and effectiveness investigations.)
Sponsors
- Robert E. Latta (primary)
- Robert B. Aderholt
- Mike Bost
- Aaron Bean
- Josh Brecheen
- Sheri Biggs
- Kat Cammack
- Michael Cloud
- Andrew S. Clyde
- Ben Cline
- Jeff Crank
- Troy Downing
- Jake Ellzey
- Randy Feenstra
- Russ Fulcher
- Michelle Fischbach
- Scott Fitzgerald
- Mike Flood
- Brad Finstad
- Vince Fong
- Julie Fedorchak
- Michael Guest
- Andy Harris
- J. French Hill
- Clay Higgins
- Kevin Hern
- Diana Harshbarger
- Erin Houchin
- Harriet M. Hageman
- Pat Harrigan
- Mike Kelly
- Mike Kennedy
- Darin LaHood
- Nicholas A. Langworthy
- Tracey Mann
- John R. Moolenaar
- Mary E. Miller
- Barry Moore
- Richard McCormick
- Mark B. Messmer
- Tim Moore
- John J. McGuire III
- Ralph Norman
- Andrew Ogles
- Robert F. Onder, Jr.
- August Pfluger
- Gary J. Palmer
- Mike Rogers
- David Rouzer
- Christopher H. Smith
- Adrian Smith
- Marlin A. Stutzman
- W. Gregory Steube
- Dale W. Strong
- Jefferson Shreve
- Glenn Thompson
- Claudia Tenney
- William R. Timmons IV
- Joe Wilson
- Tim Walberg
- Daniel Webster
- Randy K. Weber, Sr.
Text versions
- Introduced in House — 2025-01-23 — XML
What analysts say
No nonpartisan analysis on file for this measure yet.
What politicians say
No linked claims or utterances yet — no one on record has cited this measure to justify a public argument.
Action History
| Date | Action |
|---|---|
| 2025-01-23 | Introduced in House |
| 2025-01-23 | Referred to the House Committee on Energy and Commerce. |